Jun 6
|
The most popular stocks and funds investors bought in May
|
Jun 4
|
Trending tickers: Nvidia, CrowdStrike, Him & Hers, Rémy Cointreau and WH Smith
|
Jun 3
|
Hims & Hers and Zava, Credo earnings, Kenvue: Trending Tickers
|
Jun 3
|
Hims & Hers, Joby Aviation, Pinterest: Trending Tickers
|
Jun 3
|
IBD 50's Hims & Hers Erases Its 19% Acquisition-Tied Sprint
|
Jun 3
|
Hims & Hers Announces Plans to Acquire ZAVA, Accelerating Major European Growth Across the UK, Germany, France, and Ireland
|
Mar 13
|
They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick.
|
Mar 13
|
Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers
|
Mar 11
|
Define Ventures Appoints Carolyn Magill as Venture Partner
|
Mar 6
|
Walgreens stock rises amid $10 billion deal with Sycamore Partners to take the drugstore chain private
|
Mar 5
|
Hims Stock Claws Back After Novo Nordisk Undercuts It With A Cheaper Wegovy
|
Mar 5
|
Healthcare Stock Could Be Good 'Buy the Dip' Play
|
Mar 5
|
3 Growth Stocks Insiders Are Betting On
|
Mar 3
|
Hims & Hers Health (NYSE:HIMS) Jumps 40% After Projecting US$2.3 Billion Revenue for 2025
|
Feb 26
|
Hims & Hers Health Full Year 2024 Earnings: In Line With Expectations
|
Feb 25
|
Why IBD 50's Top Seed, Hims & Hers, Just Crashed On Its Upbeat Earnings
|
Feb 25
|
Hims & Hers tumbles 27% as investors fear uncertainty without compounded weight-loss drugs
|
Feb 25
|
Home Depot, Hims & Hers, bitcoin and crypto stocks: Market Minute
|
Feb 25
|
Hims & Hers stock collapses, may halt some weight-loss drug sales
|
Feb 25
|
Dow Jones Futures Rise: Trump Tariffs 'Going Forward;' Nvidia, Palantir Sell Off; Hims Plunges Late
|